Therapeutic Drug Monitoring
Showing 9926 - 9950 of >10,000
Traumatic Articular Cartilage Defects in the Knee Joint Trial in Worldwide (NOVOCART® 3D plus, Microfracture)
Active, not recruiting
- Traumatic Articular Cartilage Defects in the Knee Joint
- NOVOCART® 3D plus
- Microfracture
-
Vienna, Austria
- +34 more
Oct 11, 2021
Prostate Cancer Trial in Switzerland (Radical prostatectomy (RP) followed by ePLND, Radical prostatectomy (RP) only)
Active, not recruiting
- Prostate Cancer
- Radical prostatectomy (RP) followed by ePLND
- Radical prostatectomy (RP) only
-
Aarau, Switzerland
- +10 more
Feb 24, 2022
eFast Diagnosis Performance in Guiding First Aid Resuscitation
Completed
- eFast Diagnosis Performance in Guiding First Aid Resuscitation and Hemostasis
-
Grenoble, Cs10217, FranceUniversity Hospital of Grenoble Alpes
Feb 7, 2022
Cancer Trial in San Francisco (Device: Attune™, Device: Cerena™)
Active, not recruiting
- Cancer
- Device: Attune™
- Device: Cerena™
-
San Francisco, CaliforniaWww.Restoreclinicaltrial.Com
Oct 18, 2022
Aromatherapy Trial in Konya (Peppermint Oil, Lemon Oil, plasebo)
Recruiting
- Aromatherapy
- Peppermint Oil
- +2 more
-
Konya, TurkeyKTO Karatay University
Dec 28, 2022
Diabetes, Type II Trial in Charleston (Fenofibrate)
Completed
- Diabetes Mellitus, Type II
-
Charleston, South CarolinaMedical University of South Carolina
Jan 11, 2022
VCO2 Variation in Intensive Care as a Marker of Fluid Responsiveness, Cardiac Index Variation Transpulmonary Thermodilution in
Not yet recruiting
- VCO2 Variation in Intensive Care as a Marker of Fluid Responsiveness
- Cardiac Index Variation Transpulmonary Thermodilution in Patients on Controlled Ventilation With Shock
- impact of fluid challenge on the cardiac index and CO2 respiratory parameters analysis (VCO2, EtCO2)
-
Lyon, FranceHôpital Edouard Herriot, Anesthésie-réanimation
Jun 20, 2022
Quality of Life Trial in San Antonio (Telemonitoring sensors)
Completed
- Quality of Life
- Telemonitoring sensors
-
San Antonio, Chile
- +3 more
Nov 19, 2021
Kidney Function by Multi-modal Magnetic Resonance Imaging and
Active, not recruiting
- Kidney Transplantation
- Urinary Calculi
- diffusion MRI
- +2 more
-
Bern, SwitzerlandDepartment of Urology
Sep 29, 2021
Migraine Trial (Comparator: Rizatriptan, Comparator: Placebo)
Completed
- Migraine
- Comparator: Rizatriptan
- Comparator: Placebo
- (no location specified)
Feb 1, 2022
Pancreatic Anastomotic Leak, Pancreatic Tumors Trial in Valencia (Blumgart Anastomosis, Pancreatogastric anastomosis.)
Active, not recruiting
- Pancreatic Anastomotic Leak
- Pancreatic Neoplasms
- Blumgart Anastomosis
- Pancreatogastric anastomosis.
-
Valencia, SpainHospital Clínico Universitario de Valencia
Aug 18, 2021
Follicular Lymphoma Trial in United States (Rituximab, Utomilumab, Avelumab)
Active, not recruiting
- Follicular Lymphoma
- Rituximab
- +3 more
-
Duarte, California
- +5 more
Mar 17, 2022
Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (BAY80-6946), Placebo, Rituximab)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Copanlisib (BAY80-6946)
- +7 more
-
Chandler, Arizona
- +199 more
Jan 31, 2023
Xeljanz (Registered) in Ulcerative Colitis Patients
Completed
- Ulcerative Colitis
- Non-intervention
-
Seoul, Korea, Republic ofPfizer
Nov 16, 2022
Postural Orthostatic Tachycardia Syndrome Trial (Shared medical appointment)
Not yet recruiting
- Postural Orthostatic Tachycardia Syndrome
- Shared medical appointment
- (no location specified)
Jul 13, 2022
Pulmonary Arterial Hypertension Trial in Nashville (ESR-specific PET scan)
Recruiting
- Pulmonary Arterial Hypertension
- ESR-specific PET scan
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 26, 2022
Rosacea Trial (Brimonidine Topical Gel, 0.33 percent (Perrigo), Brimonidine Topical Gel, 0.33 percent (Reference), Placebo gel)
Completed
- Rosacea
- Brimonidine Topical Gel, 0.33 percent (Perrigo)
- +2 more
- (no location specified)
Oct 20, 2021
During Lower Body Negative Pressure Induced Controlled
Recruiting
- Hypovolemia
- Hemodynamic Instability
- Lower body negative pressure
-
New Haven, ConnecticutJohn B. Pierce Laboratory
Mar 30, 2022
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Thoracic Surgery, Cardiopulmonary Bypass Trial in Chicago (blood pressure maintenance based on cerebral blood flow
Completed
- Thoracic Surgery
- Cardiopulmonary Bypass
- blood pressure maintenance based on cerebral blood flow autoregulation measurement
- Control group
-
Chicago, IllinoisNorthwestern Memorial Hospital
Feb 10, 2021
MDD, Anxiety Trial in Kingston, Toronto (MET-2, Placebo)
Recruiting
- Major Depressive Disorder
- Anxiety
- MET-2
- Placebo
-
Kingston, Ontario, Canada
- +1 more
May 9, 2021
Tolerability of Long-Acting Nifedipine Gastrointestinal
Completed
- Hypertension
- Nifedipine controlled-release tablets(Nifedipine GITS, ADALAT, BAYA1040)
-
Multiple Locations, ChinaMany Locations
Jul 6, 2021
Overactive Bladder, Parkinson Disease Trial in United States (solifenacin, Pelvic floor muscle exercise-based behavioral
Recruiting
- Overactive Bladder
- Parkinson Disease
- solifenacin
- Pelvic floor muscle exercise-based behavioral therapy
-
Birmingham, Alabama
- +3 more
Jan 7, 2022
Parkinson Disease Trial in Toulouse (reflexology massage, sham massage)
Not yet recruiting
- Parkinson Disease
- reflexology massage
- sham massage
-
Toulouse, FranceUniversity Hospital of Toulouse
Jan 11, 2021